Reports & White Papers
Making the Switch: Why Reversal is Replacing Management for Diabetes and Weight Loss
Find out why leaders are saying goodbye to management programs that lack outcomes and ROI, and making the switch to reversal for diabetes and obesity.
How Health Plan Leaders Are Handling the GLP-1 Cost Crisis [Survey Report]
A new survey of 80 Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders shines a light on the growing GLP-1 cost crisis
Assessing Solutions to Improve Metabolic Health
A new strategy toolkit to help benefits leaders evaluate solutions to address metabolic health, including sample RFP questions.
Diabetes and Medicare Advantage: Perspectives of Older Adults [Survey Report]
A new national survey shines a light on what older adults with type 2 diabetes want from their Medicare Advantage plan.
Closing the Gap: Making More Equitable Diabetes Healthcare a Reality
How do health disparities contribute to higher prevalence and worsening outcomes in type 2 diabetes, and how can we make more equitable care a reality?
Virta is the only diabetes vendor with 3 distinct validations
The Validation Institute has now awarded Virta three distinct validations for savings, outcomes and comprehensive program.
The Reality of Reversal: Inside The Revolution in Type 2 Diabetes Treatment
Is it possible to reverse diabetes? New research says yes. Go behind the scenes of the revolution happening in diabetes care.
Virta Health Earns Validation Institute's Highest Ranking
Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.
The Real ROI Behind Virta's Diabetes Reversal Program
ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.